Related Experiment Video
Updated: Feb 6, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
An in-vivo pilot study into the effects of FDG-mNP in cancer in mice
Omer Aras1, Gillian Pearce2, Adam J Watkins3,4
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.
Purpose:
Previously, fluorodeoxy glucose conjugated magnetite nanoparticles (FDG-mNPs) injected into cancer cells in conjunction with the application of magnetic hyperthermia have shown promise in new FDG-mNPs applications. The aim of this study was to determine potential toxic or unwanted effects involving both tumour cells and normal tissue in other organs when FDG-mNPs are administered intravenously or intratumourally in mice.
Materials And Methods:
FDG-mNPs were synthesized. A group of six prostate-tumour bearing mice were injected with 23.42 mg/ml FDG-mNPs (intravenous injection, n = 3; intratumoural injection into the prostate tumour, n = 3). Mice were euthanized and histological sampling of tissue was conducted for the prostate tumour, as well as for lungs, lymph nodes, liver, kidneys, spleen, and brain, at 1 hour (n = 2) and 7 days (n = 4) post-injection. A second group of two normal (non-cancerous) mice received the same injection intravenously into the tail vein and were euthanised at 3 and 6 months post-injection, respectively, to investigate if FDG-mNPs remained in organs at those time points.
Results:
In prostate-tumour bearing mice, FDG-mNPs concentrated in the prostate tumour, while relatively small amounts were found in the organs of other tissues, particularly the spleen and the liver; FDG-mNP concentrations decreased over time in all tissues. In normal mice, no detrimental effects were found in either mouse at 3 or 6 months.
Conclusion:
Intravenous or intratumoural FDG-mNPs can be safely administered for effective cancer cell destruction. Further research on the clinical utility of FDG-mNPs will be conducted by applying hyperthermia in conjunction with FDG-mNPs in mice.
Insights
Fluorodeoxy glucose conjugated magnetite nanoparticles (FDG-mNPs) show promise for cancer treatment. Studies in mice indicate FDG-mNPs are safe when administered intravenously or intratumourally, with minimal effects on normal tissues.
Area of Science:
- Nanomedicine
- Oncology
- Biomedical Engineering
Background:
- Fluorodeoxy glucose conjugated magnetite nanoparticles (FDG-mNPs) are being explored for cancer therapy.
- Magnetic hyperthermia combined with FDG-mNPs shows potential for cancer cell destruction.
Purpose of the Study:
- To evaluate the safety and potential toxic effects of FDG-mNPs.
- To assess FDG-mNP distribution in tumor-bearing and normal mice after intravenous or intratumoural administration.
Main Methods:
- FDG-mNPs were synthesized and administered to prostate-tumor bearing mice and normal mice.
- Histological analysis of various organs was performed at different time points post-injection.
- Long-term organ retention of FDG-mNPs was investigated in normal mice.
Main Results:
- FDG-mNPs concentrated in prostate tumors with minimal distribution to other organs.
- FDG-mNP concentrations decreased over time in all examined tissues.
- No detrimental effects were observed in normal mice at 3 or 6 months post-injection.
Conclusions:
- Intravenous or intratumoural administration of FDG-mNPs appears safe for potential cancer therapy.
- FDG-mNPs can be safely administered for effective cancer cell destruction.
- Further research will explore hyperthermia in conjunction with FDG-mNPs in mice.
Related Concept Videos
Pilot and Numeric Relaying
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Biological Effects of Radiation
Effects of feedback
Feedback significantly modifies the gain of a control system. The gain of a system without feedback is altered by a factor of one plus GH, where G represents...

![Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62460.jpg&w=3840&q=50)